Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin Effect on Gastric Accommodation and Food Intake
NCT03500900Completed
- Sponsor
- UZ Leuven
- Start
- Mar 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial in type 2 diabetes mellitus (T2DM) comparing Vildagliptin with Placebo (2 arms). Primary endpoint: Intragastric pressure at 2 hours. Started Mar 2016; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03500900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500900.